Cambridge Investment Research Advisors »

Inmune Bio Ord shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Inmune Bio Ord (INMB) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Inmune Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Inmune Bio Ord held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmune Bio Ord by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $44k 21k 2.06
2025-06-30 $75k 33k 2.30
2025-03-31 $180k 23k 7.80

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Meta Platforms Inc Cl A (META)
Vanguard Index Fds Growth Etf (VUG)
Spdr Series Trust Portfolio S&P500 (SPLG)

View all positions for Cambridge Investment Research Advisors

Top funds holding Inmune Bio Ord

BlackRock
Vanguard Group
Geode Capital Management
Susquehanna International
Citadel Advisors
State Street Corporation
Raymond James Financial
Northern Trust
UBS Group
Westside Investment Management
Morgan Stanley
Wolverine Trading
Deutsche Bank Aktiengesellschaft
Bank of New York Mellon
Jpmorgan Chase & Co

View all funds holding Inmune Bio Ord